ArticleJTO clinical and research reports2025
RELAY+: Final Overall Survival With Ramucirumab Plus Gefitinib in Patients With Untreated
Makoto Nishio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it